entertainment -WSS

entertainment

author：focus 2025-10-01 14:15:28 - browse：1

Emma Walmsley on stage at the 2023 STAT Summit. — GSK CEO Emma Walmsley at the 2023 STAT Summit. STAT

The story of GSK is one of reinvention, CEO Emma Walmsley said at the STAT Summit in Boston on Thursday. Having shed its consumer division, the British drug giant is writing a new chapter as a pure-play biopharma company dedicated to the prevention, as well as treatment, of disease.

GSK’s recent launch of a new RSV vaccine for adults is emblematic of this move, adding to a portfolio that includes other vaccines, such as the very successful Shingrix for shingles, as well as drugs for HIV, other infectious diseases, and cancer, among others. But what does the growing sentiment against vaccination, not just in the United States but around the world, mean for such a bet on this market?

“It’s a very, very serious issue,” Walmsley said, noting that in 11 U.S. states, basic vaccination rates are now lower than they were before Covid. “The answer can’t be sort of flinging science over the airwaves and saying ‘trust us,’ because people don’t. There is a really serious challenge of misinformation and the ongoing issue of politicization, which I suspect is going to get more challenging in the next year for obvious reasons.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Investment in vaccine development is lagging, report finds

Wikipedia

WSS

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

The Karikó problem: Lessons for funding basic research

Readout Newsletter: The latest on Novavax, Merck, Bluebird

Investment in vaccine development is lagging, report finds

Study points to new risk in gene therapy death of Terry Horgan

Merck, Johnson & Johnson CEOs will testify on high drug prices

focus

entertainment

knowledge

Virginia high school admissions case could be legal follow

Vertex non

Activists slam private health insurers over coverage restrictions

What will Novo Nordisk's VC do with its influx of cash?

Psychedelics group wrestles with new pharma identity

What will Novo Nordisk's VC do with its influx of cash?

Sports medicine is finally prioritizing gender equality

Why Medicare shouldn’t cover every FDA

Medicare proposal to cover medical devices draws a mixed reaction

Experts study whether long Covid risk adds up with each reinfection

focus

IVG is promising — but it won’t replace IVF quite yet

Flu, Covid vaccination rates decline, new survey data show

Will an HIV vaccine ever be a reality?

IVG is promising — but it won’t replace IVF quite yet

The Affordable Care Act has saved billions in health care costs

Health Care Service Corp to buy Cigna Medicare Advantage plans

knowledge

knowledge

Wikipedia

entertainment